By using a blocking monoclonal antibody specific to the β1 integrin subunit (mAb Lia1/2), we confirmed that, in parallel to ALCAM-mediated interactions, members of the β1 integrin subfamily are also involved in EV interactions with cancer cells. This evidence concerns the gene ALCAM and cancer.